Journal of Neurology

Article	Citations
The deltoid muscle and the pattern of paresis in ALS	198
Microstructural characterization of multiple sclerosis lesion phenotypes using multiparametric longitudinal analysis	191
Neuromyelitis optica spectrum disorder with a familial Mediterranean fever gene E84K mutation	164
Tacrolimus-induced Parkinsonism	135
Halting progressive multifocal leukoencephalopathy with pembrolizumab: the case of a patient with multiple sclerosis under fingolimod	97
The DeMyers: Marian (1922–2012) and William (1924–2008)	89
Risk of secondary progression in patients with highly active multiple sclerosis treated with natalizumab: a real-life study	87
Richard Caton (1842-1926)	86
Tourette syndrome: effects of acetyl-leucine in two individuals	78
A role for the Epstein–Barr virus in multiple sclerosis aetiology?	78
Complications of reversible cerebral vasoconstriction syndrome in relation to age	77
Dizziness and spatial disorientation in patients with transient global amnesia: clinical and vestibular correlates	75
Dystonia management across Europe within ERN-RND: current state and future challenges	74
Stroke frequency, associated factors, and clinical features in primary systemic vasculitis: a multicentric observational study	73
Recent applications of quantitative electroencephalography in adult intensive care units: a comprehensive review	73
Explaining recovery from coma with multimodal neuroimaging	70
Tau levels in platelets isolated from Huntington’s disease patients serve as a biomarker of disease severity	70
A real-world study on the utility of regular rituximab treatment for neuromyelitis optica spectrum disorder	65
Pallidal deep brain stimulation for patients with myoclonus-dystonia without SGCE mutations	63
International survey on the implementation of the European and American guidelines on disorders of consciousness	62
Correction to: Synergistic effects of vagus nerve stimulation and antiseizure medication	62
Long-term safety and efficacy of ponesimod in participants with relapsing multiple sclerosis: results from the phase 3 OPTIMUM 5-year long term extension study	61
Cross-sectional brain volumetric measures and disability outcomes in relapsing–remitting multiple sclerosis	60
A decision aid is not the quick fix for improving shared decision-making in advanced Parkinson’s disease: results of a mixed methods feasibility study	57
Neurological manifestation of HEV infection: still a rare disease entity?	57

Dopaminergic responsiveness and dopaminergic challenge tests of Parkinson’s disease: a systematic review and meta-analysis	56
Long-term efficacy and safety of ravulizumab in adults with anti-acetylcholine receptor antibody-positive generalized myasthenia gravis: results from the phase 3 CHAMPION MG open-label extension	56
Incidence of Guillain–Barré syndrome in Cuba before and during the Oropouche virus emergency, 2018–2024	55
Disrupted and reorganized connectivity of brain networks in multiple sclerosis: a systematic review and meta-analysis of resting-state functional MRI	54
Primary progressive aphasia: six questions in search of an answer	54
Restless legs syndrome in Parkinson’s disease: epidemiology, pathogenetic overlaps, and clinical management	53
Historical and current issues in HIV encephalitis, and the role of neuropathology in HIV disease: a pathological perspective	50
Long-term outcome after decompressive hemicraniectomy for malignant middle cerebral artery infarction	50
Genetic forms of tauopathies: inherited causes and implications of Alzheimer’s disease-like TAU pathology in primary and secondary tauopathies	49
SARA captures disparate progression and responsiveness in spinocerebellar ataxias	49
Hashimoto’s encephalopathy with diffuse leukoencephalopathy: serial MRI and gait analysis	49
Exploring epigenetic modifications as potential biomarkers and therapeutic targets in amyotrophic lateral sclerosis	48
TS-HDS autoantibody: clinical characterization and utility from real-world tertiary care center experience	47
Acute symptomatic seizures and hippocampal sclerosis: the major contributor for post-stroke epilepsy?	46
Performance of blind source separation in localizing seizure onset from routine scalp-EEG	45
Improving conscientiousness through a smartphone app and telecoaching intervention: insights from multiple sclerosis and healthy aging samples	45
Phenotype-driven reanalysis reveals five novel pathogenic variants in 40 exome-negative families with Charcot–Marie–Tooth Disease	45
Brain 18F-FDG PET findings and sequential vestibular testing in SCA27B: a case report	45
Nomograms integrating cortical morphometric metrics with 3D multi-parametric MRI radiomics for predicting disability progression and cognitive worsening in relapsing–remitting multiple sclerosis: a mu	45
Comprehensive effects of Parkinson’s disease multimodal complex treatment (PD-MCT): a two-center prospective trial	44
Assessment of cognitive function, structural brain changes and fatigue 6 months after treatment of neuroborreliosis	44
Perceptual response characterization in acute vestibular implant stimulation	44
A retrospective study of autoimmune cerebellar ataxia over a 20-year period in a single institution	44
Humoral response after accelerated schedule of HBV vaccination in MS patients before anti-CD20 therapy	44
Keeping an eye on Parkinson’s disease: color vision and outer retinal thickness as simple and non-invasive biomarkers	43
Longitudinal predictors of health-related quality of life in isolated dystonia	43
Prevalence of hereditary transthyretin amyloidosis in CIDP patients with red flags: a multicenter genetic screening and misdiagnosis analysis	41
Analysis of C9orf72 repeat length in progressive supranuclear palsy, corticobasal syndrome, corticobasal degeneration, and atypical parkinsonism	41
Different patterns of acute saccadic response to levodopa in de novo Parkinson’s disease	40
Prevalence of infratentorial superficial siderosis in a large general population sample from the UK Biobank	40
Effects of deep brain stimulation on non-motor symptoms in Parkinson’s disease: insights from longitudinal studies using consistent evaluation scales	40
Interpretable deep learning survival predictions in sporadic Creutzfeldt–Jakob disease	40
CSF biomarkers of B-cell activation in multiple sclerosis: a clinical perspective	40
Episodic symptoms caused by neurovascular conflict of vagus nerve due to hemilateral anterior inferior cerebellar artery	38
Cavernomas: to treat or not to treat?	38
Patent foramen ovale diagnosis in young stroke patients: analysis of recurrence and mortality	38
Quantitative brainstem and spinal MRI in amyotrophic lateral sclerosis: implications for predicting noninvasive ventilation needs	38
Equity in neuromuscular research: a 20-year analysis of race, ethnicity, sex, and age representation	38
Health-related quality of life in Japanese patients with multiple sclerosis	37
eHealth tools to assess the neurological function for research, in absence of the neurologist: a systematic review, part II (hardware)	37
Regional distribution of polymorphisms associated to the disease-causing gene of spinocerebellar ataxia type 3	37
Risdiplam improves subjective swallowing quality in non-ambulatory adult patients with 5q-spinal muscular atrophy despite advanced motor impairment	37
Relapses during treatment with monoclonal antibodies targeting B-cells in NMOSD	36
The role of serum neurofilament light (sNfL) as a biomarker in multiple sclerosis: insights from a systematic review	36
Segmental distal amyotrophy and cold paresis due to chronic CSF leak with ventral longitudinal epidural collection: a case report	36
The topography of infratentorial lesions in depression and anxiety in multiple sclerosis	36
Laura Forster (1858–1917)	36
Neurological update: structural and functional imaging in epilepsy surgery	36
Non-invasive biomarkers for diagnosis and monitoring of primary mitochondrial diseases	36
Distributions and network changes of brain activity in the acute phase of anti-NMDAR encephalitis: a MEG study	35

Artificial intelligence in neurology: opportunities, challenges, and policy implications	35
Genetic modifiers of upper limb function in Duchenne muscular dystrophy	35
Sutton’s law applies to functional neurology	35
Cerebral infarctions following an increase in corticosteroids: an atypical case of reversible cerebral vasoconstriction syndrome	34
The intersection of delirium and long-term cognition in older adults: the critical role of delirium prevention	34
A novel prediction score determining individual clinical outcome 3 months after juvenile stroke (PREDICT-score)	34
Quantification of saccadic fatigability and diagnostic efficacy for myasthenia gravis	33
Challenges in multinational rare disease clinical studies during COVID-19: regulatory assessment of cipaglucosidase alfa plus miglustat in adults with late-onset Pompe disease	33
Management of hypersensitivity in a patient with late-onset Pompe disease experiencing recurrent infusion-related reactions	32
Cognitive stimulation in Parkinson’s disease with mild cognitive impairment	32
The Sternbergers: Ludwig (1921–2008) and Nancy (1938–2014)	32
Characterisation of RT-QuIC negative cases from the UK National CJD Research and Surveillance programme	32
Cost effectiveness of different treatment strategies with natalizumab for pregnant women with multiple sclerosis	32
Correction: Pharmacogenomics of clinical response to Natalizumab in multiple sclerosis: a genome-wide multi-centric association study	31
Bilateral beaded watershed infarction secondary to acute anemia from gastrointestinal bleeding	31
Endolymphatic space is age-dependent	31
Evaluating 18F-Florzolotau tau PET for Alzheimer’s disease diagnosis with 18F-Flortaucipir as reference	31
Encephalitis in HIV-infected adults in the antiretroviral therapy era	31
The frequency of non-motor symptoms in SCA3 and their association with disease severity and lifestyle factors	30
Procedural and Clinical Outcome of Stroke after thrombectomy according to etiology: results from a nationwide registry	30
Frontotemporal neurofibrillary tangles and cerebrovascular lesions are associated with autism spectrum behaviors in late-life dementia	30
Proposal of new diagnostic criteria for fatal familial insomnia	30
Left- vs right-sided migraine: a scoping review	30
Aphasia as a stroke mimic in older adults: a diagnostic challenge	30
The clinical phenotype of psychiatric-onset prodromal dementia with Lewy bodies: a scoping review	30
Genetic variation of low-to-medium-affinity Fc-gamma receptors in Guillain-Barré syndrome	30
Machine learning for adaptive deep brain stimulation in Parkinson’s disease: closing the loop	29
Ozone pollution as a possible trigger for multiple sclerosis in young people: the PEDIGREE study	29
Translocator protein (TSPO)-PET as diagnostic and monitoring tool in COVID-19 related MRI-negative brainstem encephalitis: a case report	29
Mismatch between clinically defined classification of ALS stage and the burden of cerebral pathology	29
A multi-domain lifestyle intervention in multiple sclerosis: a longitudinal observational study	29
The complex relationship between antibody titers and clinical outcome in botulinum toxin type A long-term treated patients with cervical dystonia	29
Estimation of ataxia severity in children with ataxia-telangiectasia using ankle-worn sensors	29
Systematic review and evidence gap mapping of biomarkers associated with neurological manifestations in patients with COVID-19	29
Regional brain atrophy subtypes in spinocerebellar ataxia type 3: links to clinical performance and treatment response	29
Matched-pair analysis of motor outcomes in adults with spinal muscular atrophy on nusinersen vs. risdiplam	28
Feasibility, safety and efficacy of multi-dose vagus nerve stimulation in Parkinson’s disease: a double-blind, randomised sham-controlled proof-of-concept study	28
Air pollution, greenspace exposure and risk of Parkinson's disease: a prospective study of 441,462 participants	28
Architecture and anatomy of executive processes: evidence from verbal fluency and Trail Making Test in 2009 stroke patients	28
Retreating migraine patients in the second year with monoclonal antibodies anti-CGRP pathway: the multicenter prospective cohort RE-DO study	28
Inflammatory neuropathy with evidence of anti-GQ1b antibodies in angioimmunoblastic T cell lymphoma (AITL): a case report	28
Dysregulation of the molecular clock by blood-borne factors in Alzheimer’s disease patients	28
Anxiety and depression in Charcot-Marie-Tooth disease: data from the Italian CMT national registry	28
Effects of transcutaneous auricular vagus nerve stimulation on motor and gait performance in Parkinson’s disease: a meta-analysis of randomized controlled trials	28
Present and future of the diagnostic work-up of multiple sclerosis: the imaging perspective	27
Regional free-water diffusion is more strongly related to neuroinflammation than neurodegeneration	27
Longitudinal analysis and treatment of neuropsychiatric symptoms in post-acute sequelae of COVID-19	27
The role of language-related functional brain regions and white matter tracts in network plasticity of post-stroke aphasia	27
Impulse control and correlation to dopamine agonist serum concentrations in people with Parkinson's disease	27
Novel biomarkers and neuroimaging techniques in Parkinson’s disease	27
Long-term clinical outcomes in patients with CIS treated with interferon beta-1b: results from the 15-year follow up of the BENEFIT trial	27
Is there a spinal tap responder in progressive supranuclear palsy? The first prospective study	27
Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study	27
Detection of patent foramen ovale in patients with ischemic stroke on prospective ECG-gated cardiac CT compared to transthoracic echocardiography	27
Longitudinal qualitative assessment of meaningful symptoms and relevance of WATCH-PD digital measures for people with early Parkinson’s	27
Rate of change in upper and lower motor neuron burden is associated with survival in amyotrophic lateral sclerosis	27
Efficacy and safety of monoclonal antibodies in the treatment of relapsing remitting multiple sclerosis: a systematic review	27
Outcome predictors of post-COVID conditions in the European Academy of Neurology COVID-19 registry	27
Analyzing the relationship between specific brain structural changes and the diffusion tensor image analysis along the perivascular space index in idiopathic normal pressure hydrocephalus	27
Amyotrophic lateral sclerosis stratification: unveiling patterns with virome, inflammation, and metabolism molecules	27
Audiovisual analysis of the diagnostic video polysomnography in patients with isolated REM sleep behavior disorder	27
Progression independent of relapse activity in relapsing multiple sclerosis: impact and relationship with secondary progression	27
Precision diagnosis and precision treatment for the genetic epilepsies	26
Late-onset cerebellar ataxia in three European patients with repeat expansions in RFC1 and FGF14: a case series	26
Beneficial effect of N-acetyl-DL-leucine on cognitive function, emotional well-being and QoL in a mentally healthy elderly person	26
Usefulness of subcutaneous immunoglobulin therapy in the management of myasthenia gravis: a retrospective cohort study	26
MRI-guided focused ultrasound: new hope for drug-resistant neurological conditions	26
Genetic risk factors of Alzheimer’s Disease disrupt resting-state functional connectivity in cognitively intact young individuals	26
Loss of brainstem white matter predicts onset and motor neuron symptoms in C9orf72 expansion carriers: a GENFI study	26
Neurogenic cough in CANVAS syndrome: objective cough monitoring reveals a distinctive clinical pattern	25
Diagnosing primary lateral sclerosis: a clinico-pathological study	25
Different approaches to test orientation of self in space: comparison of a 2D pen-and-paper test and a 3D real-world pointing task	25
Intake reminders are effective in enhancing adherence to direct oral anticoagulants in stroke patients: a randomised cross-over trial (MAAESTRO study)	25
A new genetic cause of spastic ataxia: the p.Glu415Lys variant in TUBA4A	25
Rho GTPase-activating protein 10 (ARHGAP10/GRAF2) is a novel autoantibody target in patients with autoimmune encephalitis	25
Evaluation of drivers of treatment switch in relapsing multiple sclerosis: a study from the Italian MS Registry	25
Natural history of facioscapulohumeral muscular dystrophy evaluated by multiparametric quantitative MRI: a prospective cohort study	25
The role of age in choosing high-efficacy treatment for multiple sclerosis: an Austrian MS Database study	24
The impact of the SARS-CoV-2-pandemic on patients with chronic inflammatory neuropathies: results from the German INHIBIT register	24
Unprescribed cannabinoids and multiple sclerosis: a multicenter, cross-sectional, epidemiological study in Lombardy, Italy	24

Subjective and objective responses to caloric stimulation help separate vestibular migraine from other vestibular disorders	24
The value of magnetic resonance imaging of the optic nerve for the diagnosis of multiple sclerosis in patients with optic neuritis	24
Comparing caloric and self-experienced dizziness symptoms: diagnostic value and implications in functional dizziness	24
Reassessing the adverse event profiles of levetiracetam and brivaracetam: a systematic review and meta-analysis	24
Visual quality of life in NMOSD and MOGAD: profiles, dynamics and associations with ageing and vision	24
Frida Kahlo could have had cauda equina syndrome: a case report	24
Correction: Metabolomic profile of cerebrospinal fluid from patients with diffuse gliomas	24
Measurement of upper limb function in ALS: a structured review of current methods and future directions	24
Diagnostic accuracy and confounders of vagus nerve ultrasound in amyotrophic lateral sclerosis—a single-center case series and pooled individual patient data meta-analysis	24
Occurrence of area postrema syndrome during follow-up: phenotype and influence over NMOSD activity in LATAM in real-world settings	24
Brain positron emission tomography (PET) and cognitive abnormalities one year after COVID-19	24
Modulation of spontaneous motor unit potentials by a new motor cortical magnetic stimulation method in amyotrophic lateral sclerosis	24
Hypothalamic atrophy in CANVAS/RFC1	24
Correction: Opicapone for the treatment of early wearing-off in levodopa-treated Parkinson’s disease: pooled analysis of patient level data from two randomized open-label studies	24
Fingolimod-associated progressive multifocal leukoencephalopathy in a multiple sclerosis patient with a good response to filgrastim	24
Refractory focal epilepsy evolving into a Lennox–Gastaut syndrome-like	24
Could galcanezumab modulate inflammatory cytokines? A single-centre exploratory study	23
Parkinson’s disease with hyposmia and dysautonomia: does it represent a distinct subtype?	23
CSF phospho-tau levels at Parkinson’s disease onset predict the risk for development of motor complications	23
Distal hereditary motor neuronopathy as a new phenotype associated with variants in BAG3	23
Locus coeruleus degeneration and cerebellar gray matter changes in essential tremor	23
Correlation between cognitive changes and neuroradiological changes over time in multiple sclerosis: a systematic review and meta-analysis	23
Integrating standard and native spaces for radiomics and brain network analysis in Alzheimer’s disease diagnosis and prognosis	23
Accuracy of the central vein sign in diagnosis of multiple sclerosis: a systematic review and meta-analysis	23
Recurrence and long-term outcomes of Tolosa-Hunt syndrome	23
Quantitative whole-body muscle MRI in idiopathic inflammatory myopathies including polymyositis with mitochondrial pathology: indications for a disease spectrum	23
Effectiveness and safety of pharmacological prophylaxis for chronic migraine: a systematic review and network meta-analysis	22
Retinal thickness as a biomarker of cognitive impairment in manifest Huntington’s disease	22
Dopamine transporter single photon emission computed tomography (DaT-SPECT) use in the diagnosis and clinical management of parkinsonism: an 8-year retrospective study	22
Effect of siponimod on lymphocyte subsets in active secondary progressive multiple sclerosis and clinical implications	22
Measuring cognitive impairment and monitoring cognitive decline in Huntington’s disease: a comparison of assessment instruments	22
Treatment of functional neurological disorder: an umbrella review of systematic reviews and meta-analyses	22
Frequency and predictors of poststroke epilepsy after mechanical thrombectomy for large vessel occlusion stroke: results from a multicenter cohort study	22
Association of rare variants in genes of immune regulation with pediatric autoimmune CNS diseases	22
The correlation between 9-HPT and patient-reported measures of upper limb function in multiple sclerosis: a systematic review and meta-analysis	22
Specific clinical and radiological characteristics of anti-NMDA receptor autoimmune encephalitis following herpes encephalitis	22
Epileptogenicity of white matter lesions in cerebral small vessel disease: a systematic review and meta-analysis	22
Efficacy and safety of adjunctive perampanel treatment in pediatric patients with epilepsy aged 4–12 years: a real-world study	22
Widespread and progressive brain atrophy is a common feature in patients with mitochondrial disease	22
Overcoming traps and pitfalls leading to misinterpretation of normal EEG variants and variation of the background activity	22
Incidence of cerebral small vessel disease-related MR markers in the Swedish general population ‘Good Aging in Skåne’(GÅS) study	22
Impacts of medication non-adherence to major modifiable stroke-related diseases on stroke prevention and mortality: a meta-analysis	21
Effectiveness of endovascular treatment for in-hospital stroke vs. community-onset stroke: a propensity score-matched analysis	21
Orthostatic blood pressure trajectories characterize heterogeneous disease progression in Parkinson's disease	21
Exploring the impact of 40 Hz multi-luminaire light exposure in Alzheimer's dementia: insights from a convenient sampling, non-randomized case–control study	21
Good vibrations: tactile cueing for freezing of gait in Parkinson’s disease	21
Motor and non-motor outcome in tremor dominant Parkinson’s disease after MR-guided focused ultrasound thalamotomy	21
Effects of motor–cognitive training on dual-task performance in people with Parkinson’s disease: a systematic review and meta-analysis	21
Isolated REM sleep behaviour disorder: current diagnostic procedures and emerging new technologies	21
Case report: anti-argonaute antibodies in Epstein-Barr virus encephalitis	21
Fluctuations in serum aquaporin-4 antibody titers: the clinical significance in neuromyelitis optica spectrum disorder	21
Systematic assessment of square-wave jerks in progressive supranuclear palsy: a video-oculographic study	21
Muscle MRI as a biomarker of disease activity and progression in myotonic dystrophy type 1: a longitudinal study	21
Acetyl-dl-leucine in cerebellar ataxia ([18F]-FDG-PET study): how does a cerebellar disorder influence cortical sensorimotor networks?	20
Satralizumab as a treatment for pediatric-onset neuromyelitis optica spectrum disorder with cluster attack: a case report	20
Louis Jacobsohn-Lask (1863–1940)	20
Plasma NfL and GFAP in the preclinical stages of neurodegenerative diseases: insights from the UK Biobank	20
The effects of dopaminergic medication and task load on trembling and akinetic freezing of gait in Parkinson’s disease	20
Muscle quantitative MRI as a novel biomarker in hereditary transthyretin amyloidosis with polyneuropathy: a cross-sectional study	20
Diagnostic utility of neurofilament markers for MND is limited in restricted disease phenotype and for differentiation from compressive myeloradiculopathies	20
Upper motor neuron-predominant motor neuron disease: a novel immunotherapy-responsive association of GAD65 autoimmunity	20
Conjugate torsional pendular nystagmus and palatal tremor after unilateral internuclear ophthalmoplegia	20
Spinocerebellar ataxia 27B: a frequent and slowly progressive autosomal-dominant cerebellar ataxia—experience from an Italian cohort	20
Leg stereotypy syndrome: phenomenological and quantitative analysis	20
Pathological findings in autoimmune encephalitis autopsy specimens from cases of suspected prion disease	20
Chronic vertigo and central oculomotor dysfunction with evidence of anti-ITPR1 antibodies	20
(William) Ritchie Russell (1903–1980)	20
The impact of spontaneous intracranial hypotension on social life and health-related quality of life	20
Early use of high-efficacy therapies in multiple sclerosis in the United States: benefits, barriers, and strategies for encouraging adoption	20
The impact of an MSU service on acute stroke care in a middle-sized city: a simulation-based analysis	20
Endovascular thrombectomy with or without intravenous alteplase in acute stroke: a systematic review and meta-analysis of randomized clinical trials	19
Comparison of clinical features in patients with vestibular migraine and migraine	19
Olfactory dysfunction is common in classical infratentorial superficial siderosis of the central nervous system	19
Abuse and revictimization in adulthood in multiple sclerosis: a cross-sectional study during pregnancy	19
Characteristics of HHV-7 meningitis: a systematic review	19
A nationwide epidemiological study of myasthenia gravis in Turkey	19
Eye movement abnormalities in normal pressure hydrocephalus: a video-oculographic study	19
Traumatic brain injury incidence and mortality: a large population-based study	19
NFL and GFAP in (pre)symptomatic RVCL-S carriers: a monogenic cerebral small vessel disease	19
A novel phenotype in an Italian family with a rare progranulin mutation	19
Microvascular involvement in migraine: an optical coherence tomography angiography study	19
NMOSD typical brain lesions after COVID-19 mRNA vaccination	19
Risk and sex-specific trends of dementia and stroke in Italy Compared to European and high-income countries and the world: global implications	19
A disproportionality analysis of surgical site infections across multiple sclerosis disease modifying therapies	19
The phenotypic spectrum of epilepsy associated with periventricular nodular heterotopia	19
Sleep characteristics and risk of Alzheimer’s disease: a systematic review and meta-analysis of longitudinal studies	19
A rare case of a wall-eyed bilateral internuclear ophthalmoplegia (WEBINO) syndrome in a patient with cutaneous lupus erythematosus after COVID-19 infection	19
Combined central and peripheral demyelination after COVID-19 vaccination	19
Frataxin analysis using triple quadrupole mass spectrometry: application to a large heterogeneous clinical cohort	19
Optic neuritis and MOGAD	19
Correction to: Outcomes of mechanical thrombectomy in patients with acute ischemic stroke and thrombocytopenia: systematic review and meta-analysis	19
Marked increase in severe neurological disorders after nitrous oxide abuse: a retrospective study in the Greater Paris area	19
Explaining cognitive function in multiple sclerosis through networks of grey and white matter features: a joint independent component analysis	19
Accuracy of clinical diagnosis in neurodegenerative diseases - a study of 455 autopsy cases	18
Elevated serum concentrations of GFAP in hereditary transthyretin amyloidosis since pre-symptomatic stages	18